

Other version: http://link.springer.com/10.1007/s00259-019-04466-6
![]() |
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease |
|
Authors | ![]() | |
Published in | European journal of nuclear medicine and molecular imaging. 2020, vol. 47, no. 2, p. 270-280 | |
Abstract | PURPOSE: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-tau) in AD diagnosis in patients with mild cognitive impairment (MCI) or mild dementia, in order to improve the definition of diagnostic algorithm. | |
Keywords | Alzheimer's disease — Cerebrospinal fluid — Incremental diagnostic value — Mild cognitive impairment — Positron emission tomography | |
Identifiers | PMID: 31388720 | |
Full text |
![]() ![]() Other version: http://link.springer.com/10.1007/s00259-019-04466-6 |
|
Structures | ||
Research groups | Laboratoire de neuroimagerie et de traceurs moléculaires innovants (984) Neuropsychologie et neurologie comportementale (951) Troubles de mémoire et maladie d'Alzeimer (935) | |
Project | Swiss National Science Foundation: 320030_169876 | |
Citation (ISO format) | RAMUSINO, Matteo Cotta et al. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease. In: European Journal of Nuclear Medicine and Molecular Imaging, 2020, vol. 47, n° 2, p. 270-280. doi: 10.1007/s00259-019-04466-6 https://archive-ouverte.unige.ch/unige:132778 |